Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann Intensive Care ; 1(1): 26, 2011 Jul 19.
Artigo em Inglês | MEDLINE | ID: mdl-21906376

RESUMO

BACKGROUND: Continuous infusion of vancomycin is increasingly preferred as an alternative to intermittent administration in critically ill patients. Intermittent vancomycin treatment is associated with an increased occurrence of nephrotoxicity. This study was designed to determine the incidence and risk factors of acute kidney injury (AKI) during continuous infusion of vancomycin. METHODS: This was a retrospective, observational, two-center, cohort study in patients with microbiologically documented Gram-positive pneumonia and/or bacteremia and normal baseline renal function. Vancomycin dose was adjusted daily aiming at plateau concentrations of 15-25 µg/mL. AKI was defined as an increase in serum creatinine of 0.3 mg/dL or a 1.5 to 2 times increase from baseline on at least 2 consecutive days after the initiation of vancomycin. Primary data analysis compared patients with AKI with patients who did not develop AKI. A binary logistic regression analysis using the forward stepwise method was used to assess the risk factors associated with AKI. RESULTS: A total of 129 patients were studied of whom 38 (29.5%) developed AKI. Patients with AKI had higher body weight (77.3 ± 15 vs. 70.5 ± 15.2 kg; p = 0.02), more diabetes (79% vs. 54%; p = 0.01), and a higher vasopressor need (87% vs. 59%; p = 0.002). Serum vancomycin levels, body weight, and SAPS 3 score were identified as variables contributing to AKI. The incidence of AKI increased substantially when treatment duration was prolonged (14.9 ± 9.8 vs. 9.2 ± 4.9 days; p = 0.05) and plasma levels exceeded 30 µg/mL. CONCLUSIONS: AKI is frequently observed during continuous vancomycin infusion, particularly when conditions that cause acute (shock) or chronic (diabetes) renal dysfunction are present and vancomycin levels above target range are achieved. Although this study challenges the concept that continuous vancomycin infusion might alleviate the risk of nephrotoxicity in critically ill patients, a direct relationship between vancomycin and nephrotoxicity remains to be proven.

2.
Cardiovasc Revasc Med ; 11(3): 170-1, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20599169

RESUMO

A patient with previous implantation of two stents in the left renal artery (because of refractory arterial hypertension) developed, 7 months after implantation, a renal infarction due to late renal stent thrombosis. The early diagnosis by means of computed tomography of the abdomen and the rapid intervention by means of percutaneous balloon angioplasty lead to a favorable outcome.


Assuntos
Cateterismo/métodos , Obstrução da Artéria Renal/etiologia , Obstrução da Artéria Renal/terapia , Stents/efeitos adversos , Trombose/etiologia , Trombose/terapia , Angiografia/métodos , Angioplastia com Balão/efeitos adversos , Angioplastia com Balão/métodos , Anticoagulantes/uso terapêutico , Terapia Combinada , Meios de Contraste , Seguimentos , Humanos , Hipertensão Renal/diagnóstico por imagem , Hipertensão Renal/terapia , Masculino , Pessoa de Meia-Idade , Falha de Prótese , Obstrução da Artéria Renal/diagnóstico por imagem , Medição de Risco , Trombose/diagnóstico por imagem , Tomografia Computadorizada por Raios X/métodos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...